News, Deals & Cases

On 12 March 2018, Sensirion Holding AG (Sensirion) announced the launch of its initial public offering (IPO) on SIX Swiss Exchange and the first trading day was March 22, 2018. The shares of Sensirion were priced at CHF 36 per share, at the top end of the price range, corresponding to a placement volume of…

On 12 March 2018, Medartis Holding AG (Medartis) announced the launch of its initial public offering (IPO) on SIX Swiss Exchange and the first trading day was March 23, 2018. The shares of Medartis were priced at CHF 48 per share, corresponding to a placement volume of CHF 123.9 million (excluding the over-allotment option) and…

Orior AG successfully placed 592,499 new shares by way of an accelerated bookbuilding in a private placement with institutional investors. The placed shares are sourced from the company’s existing authorized share capital and the pre-emptive rights of the existing shareholders have been excluded.

Novartis Finance S.A. completed the placement of EUR 750,000,000 Guaranteed Notes due 2023, EUR 750,000,000 Guaranteed Notes due 2030 and EUR 750,000,000 Guaranteed Notes due 2038. The 2023 Notes were issued at 99.655% of their principal amount with an interest of 0.500% and will mature on 14 August 2023 at their nominal value. The 2030…

On 9 November 2017, Valora Holding AG (Valora) launched its right offering of up to 687’119 registered shares. On 21 November 2017, Valora Holding AG completed the capital increase raising net proceeds of approximately CHF 166 million. The capital increase was executed as an “at market” rights offering. The offer price for the new shares…

On 16 November 2017 St.Galler Kantonalbank AG (SGKB) launched, and on 30 November 2017 successfully completed, the issuance of CHF 100 million 1.70 per cent. Perpetual Additional Tier 1 Notes and CHF 100 million 1.00 per cent. Tier 2 Notes due 2027 (collectively, the Notes). The Notes are governed by Swiss law, eligible to count…

On 3 November 2017, the Dufry group concluded the refinancing of its main bank credit facilities of CHF 3.4 billion. The refinancing of the bank credit facilities concluded the restructuring of Dufry’s financing structure, including the issuance of the EUR 800 million Senior Notes on 24 October 2017.

On 23 October 2017, ADC Therapeutics SA, an oncology drug discovery and development company that specializes in the development of Antibody Drug Conjugates (ADCs) targeting major cancers, announced that it has raised USD 200 m through a private placement of shares. According to BioWorld.com, the placement is the fourth largest private financing round on record…

With its decision dated 22 November 2017 (0630 / 03 – gategroup Holding AG), the Swiss Takeover Board (TOB) asserted that the information about the offeror, HNA Aviation (Hong Kong) Air Catering Holding Co., Ltd., as disclosed in the Offer Prospectus dated 20 May 2016 is partially untrue respectively incomplete. The review body Ernst &…